1. Home
  2. PKST vs ESPR Comparison

PKST vs ESPR Comparison

Compare PKST & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peakstone Realty Trust

PKST

Peakstone Realty Trust

HOLD

Current Price

$20.99

Market Cap

780.2M

Sector

Real Estate

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKST
ESPR
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
780.2M
731.9M
IPO Year
2014
2013

Fundamental Metrics

Financial Performance
Metric
PKST
ESPR
Price
$20.99
$3.14
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$21.00
$8.75
AVG Volume (30 Days)
346.2K
16.4M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
$105,981,000.00
$403,135,000.00
Revenue This Year
$12.08
N/A
Revenue Next Year
$10.03
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$11.50
$0.76
52 Week High
$21.00
$4.18

Technical Indicators

Market Signals
Indicator
PKST
ESPR
Relative Strength Index (RSI) 78.34 71.19
Support Level $20.72 $2.37
Resistance Level N/A $3.18
Average True Range (ATR) 0.02 0.07
MACD -0.02 0.13
Stochastic Oscillator 85.71 96.74

Price Performance

Historical Comparison
PKST
ESPR

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: